118 related articles for article (PubMed ID: 15183094)
1. Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis.
Gaines Das RE; Brügger P; Patel M; Mistry Y; Poole S
J Immunol Methods; 2004 May; 288(1-2):165-77. PubMed ID: 15183094
[TBL] [Abstract][Full Text] [Related]
2. Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes.
Poole S; Thorpe R; Meager A; Gearing AJ
Dev Biol Stand; 1988; 69():121-3. PubMed ID: 3265674
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of human monocytes for pharmacopeial monocyte activation test.
Koryakina A; Frey E; Bruegger P
J Immunol Methods; 2014 Mar; 405():181-91. PubMed ID: 24456627
[TBL] [Abstract][Full Text] [Related]
4. Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin.
Perdomo-Morales R; Pardo-Ruiz Z; Spreitzer I; Lagarto A; Montag T
ALTEX; 2011; 28(3):227-35. PubMed ID: 21993958
[TBL] [Abstract][Full Text] [Related]
5. An improved monocyte activation test using cryopreserved pooled human mononuclear cells.
Solati S; Aarden L; Zeerleder S; Wouters D
Innate Immun; 2015 Oct; 21(7):677-84. PubMed ID: 25907070
[TBL] [Abstract][Full Text] [Related]
6. Validation of the monocyte activation test with three therapeutic monoclonal antibodies.
Daniels R; Van der Elst W; Dieltjens N; Appels T; So CK; Nys T; Voeten L; Breugelmans P; Molenaar-de Backer MWA; Gitz E; Poole S; Patel M
ALTEX; 2022; 39(4):621–635. PubMed ID: 35502618
[TBL] [Abstract][Full Text] [Related]
7. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.
Kikkert R; de Groot ER; Aarden LA
J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276
[TBL] [Abstract][Full Text] [Related]
8. [LAL (Limulus Amoebocyte Lysate) test as applied to the safety evaluation of biological preparations].
Aleksandrowicz J; Kudelski Z
Rocz Panstw Zakl Hig; 1997; 48(3):275-82. PubMed ID: 9432705
[TBL] [Abstract][Full Text] [Related]
9. Standardization of whole blood assay for determination of pyrogenic activity in organic dust samples.
Liebers V; Stubel H; Düser M; Brüning T; Raulf-Heimsoth M
Int J Hyg Environ Health; 2009 Sep; 212(5):547-56. PubMed ID: 19395310
[TBL] [Abstract][Full Text] [Related]
10. International validation of pyrogen tests based on cryopreserved human primary blood cells.
Schindler S; Spreitzer I; Löschner B; Hoffmann S; Hennes K; Halder M; Brügger P; Frey E; Hartung T; Montag T
J Immunol Methods; 2006 Oct; 316(1-2):42-51. PubMed ID: 16996078
[TBL] [Abstract][Full Text] [Related]
11. New Applications of the Human Whole Blood Pyrogen Assay (PyroCheck).
Fennrich S; Wendel A; Hartung T
ALTEX; 1999; 16(3):146-149. PubMed ID: 11107322
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide.
Park CY; Jung SH; Bak JP; Lee SS; Rhee DK
Biologicals; 2005 Sep; 33(3):145-51. PubMed ID: 16055344
[TBL] [Abstract][Full Text] [Related]
13. Current practices in endotoxin and pyrogen testing in biotechnology. The Quality Assurance/Quality Control Task Group. Parenteral Drug Association.
J Parenter Sci Technol; 1990; 44(1):39-45. PubMed ID: 2313492
[TBL] [Abstract][Full Text] [Related]
14. Assay of pyrogens by interleukin-6 release from monocytic cell lines.
Taktak YS; Selkirk S; Bristow AF; Carpenter A; Ball C; Rafferty B; Poole S
J Pharm Pharmacol; 1991 Aug; 43(8):578-82. PubMed ID: 1681074
[TBL] [Abstract][Full Text] [Related]
15. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
16. Testing medical disposables using the Limulus Amoebocyte Lysate (LAL) test.
Pfeiffer M
Med Device Technol; 1990; 1(3):37-41, 51. PubMed ID: 10149427
[TBL] [Abstract][Full Text] [Related]
17. A rapid 'one-plate' in vitro test for pyrogens.
Poole S; Mistry Y; Ball C; Gaines Das RE; Opie LP; Tucker G; Patel M
J Immunol Methods; 2003 Mar; 274(1-2):209-20. PubMed ID: 12609546
[TBL] [Abstract][Full Text] [Related]
18. In vitro pyrogen test--A new test method for solid medical devices.
Mazzotti F; Beuttler J; Zeller R; Fink U; Schindler S; Wendel A; Hartung T; von Aulock S
J Biomed Mater Res A; 2007 Feb; 80(2):276-82. PubMed ID: 16958052
[TBL] [Abstract][Full Text] [Related]
19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
20. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
